Chiasma

www.amrytpharma.com

Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma

Read more

Reach decision makers at Chiasma

Lusha Magic
My account

Free credit every month!

Chiasma Logo

Chiasma

www.amrytpharma.com

Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma

Read more
icon

Country

Ireland

icon

City (Headquarters)

Dublin

icon

Industry

Biotechnology Research

icon

Estimated Revenue

$10,000,000 to $50,000,000

icon

Social

  • icon

Employees statistics

View all employees

2

Others

Show All

3

Managers

Show All

3

Director

Show All

Potential Decision Makers

  • Member Board of Directors

    Email ****** @****.com
    Phone (***) ****-****

  • Director , National Accounts at Chiasma

    Email ****** @****.com
    Phone (***) ****-****

  • Senior Director , Head of Scientific Communications

    Email ****** @****.com
    Phone (***) ****-****

  • Territory Business Manager , Great Plains

    Email ****** @****.com
    Phone (***) ****-****
Show more

Technologies

(39)

Reach decision makers at Chiasma

Free credits every month!

My account

Chiasma FAQ

Sign up now to uncover all the contact details

My account